ABSTRACT
INTRODUCTION
The workplace drug testing (WDT) in USA is an established practice, carried out according to national guidelines for different purpose (as pre-employment screening, testing for cause, for scheduled categories of employers or random testing, etc.) [1] [2] [3] [4] using either urine/blood or alternative matrices (oral fluid, hair, sweat, breath air) [5, 6] . On the contrary, in Europe, the WDT is regulated by a patchwork of legislation or lack of it [7] [8] [9] . On one hand, many European countries recognize that toxicological controls might contribute to the improvement of safety in the workplace. However, they have difficulties in defining "scheduled categories of safety-critical jobs" and in proposing appropriate protocols to recognize cases of drug abuse or of excessive ethyl alcohol intake. In Italy, since October 2008, a specific law on the WDT is applied only to "workers were performing scheduled hazardous jobs," in order to discourage the abuse of illicit substances and to reduce the likelihood of accidents. That law was introduced in accordance with the agreement of the Government/Region Conference [10, 11] and with a Decree on Health and Safety at work [12] . It establishes that WDT must be carried out according two levels of mandatory standardized procedures. These procedures define the sample collection, the storage, the whole chain of custody of the biological samples and the analytical techniques that have to be used with related cut-off:
• First level procedure is based on clinical observation (anamnesis, medical, and psychiatric examination) that are coupled with toxicological tests on urine for opiates, cocaine, amphetamines, and analogues, cannabinoids, methadone and buprenorphine, and performed by occupational doctors using immunochemical methodology.
Each positive result must be confirmed in authorized toxicological laboratories by spectrometric methodology (gas chromatography/mass spectrometry [GC/MS] or liquid chromatography [LC] -MS/MS).
In cases of a positive result for "taking drugs and/or psychotropic substances," regardless of the presence of "addiction," the occupational health physician establishes a period of temporary inability. Therefore, for the safety of the individual and of the community, the employee has to change his work function. Consequently, he is entrusted to a specialized service for the treatment of the addiction, at maximum for a period of 3 years.
• Second level procedure is based on toxicological controls on urine and/or hair samples (length 3.5 cm) as for the previous used drug and for the other scheduled drugs, in order to prove that the subject is drug free. These analyses had to be performed by laboratories of forensic toxicology using GC/MS or LC-MS/MS, after the rehabilitation and before the readmission to the previous work function.
In Italy, up to 2008, the WDT -If required to apply the art. 124/125 (general employees) or the art. 108/109 (military workers) of the Unified Text of Laws on the psychotropic drug (DPR 309/90) [13] -was mainly performed by public laboratories of the National Health Service, without specific guidelines. Therefore, in the past decade, the Italian epidemiological data concerning the drug abuse among workers were very fragmentary [14] [15] [16] .
Since October 2008, the declared objectives introduced by the Decree on Health and Safety at work are: a. Prevent accidents in workers performing "hazardous job" to improve the safety of the employees, of co-workers and the general population b. Protect the privacy and dignity of the person during the assessment procedures on the drug use, avoiding a persecutory use of the controls or impairing the right of the worker c. Ensure reliability and methodological uniformity in the toxicological diagnostic procedures, according to the shared quality criteria.
The aim of this study is to perform an update on the effectiveness of the Italian current legislation on the WDT, in order to evaluate its impact on the prevalence of drug use among workers. Dilemmas concerning the professional responsibility connected to the management of the toxicological controls and its ethical implications are also discussed.
MATERIALS AND METHODS
The toxicological analyses performed from 2001 to 2014, to assess the suitability for "at-risk work activities" of 73,656 workers, were selected for the present study. Workers enrolled (aged between 19 and 65 years; 92% males and 8% females)
were mainly employed in public or private transports (bus, taxi, trucking, train, and airplane drivers, flight controllers, railway, and maritime staff).
For 3934 urine samples, the confirmatory analysis by GC-MS has been requested to the Laboratory of Forensic Toxicology of the Second University of Naples (Italy). These samples were identified as positive for one or more drugs by immunoassay screening tests (for opiates, methadone, cannabinoids, cocaine, buprenorphine, amphetamines, and analogues) previously applied in the workplace area by the specialists in occupational medicine. All urine samples were delivered to the laboratory, frozen (−20°C) and accompanied by documented forms concerning the chain of custody and the written informed consent.
Confirmation analyses were performed according to the protocols established by the Italian Law [10, 11] and the procedures suggested by the Guidelines of the Italian Group of Forensic Toxicologists [17] which are consistent with the recommendation of the European WDT Society [18] .
GC-MS analyses were carried out using a gas chromatograph Agilent 6890 equipped with an agilent mass detector model 5973 N operating in SIM mode (three ions for each analyte). Calibration curves were prepared by spiking drug-free urine with certified standards of 11-nor-∆ 9 -tetrahydrocannabinol-9-carboxylic acid (THC-COOH), morphine, codeine, 6-acetylmorphine, cocaine, benzoylecgonine, methadone, EDDP, amphetamines and analogues, buprenorphine, norbuprenorphine, and the corresponding deuterated compounds, used as internal standard (from Cerilliant-UK).
Linearity with a correlation coefficient r 2 >0.999 was achieved within the ranges of 2-200 ng/ml for THC-COOH and 5-500 ng/ml for the other drugs, respectively. Intra-assay data on precision and robustness were evaluated at three concentrations (cut-off, medium and high) for all analytes. In general, the coefficient of variation percentage was always lower than 20% for samples spiked at the cut-off level and lower than 15% for "medium" and "high" concentrations. The limit of detection (LOD) and limit of quantization were respectively 2 and 5 ng/ml for THC-COOH and 5-20 ng/ml for the other basic drugs. Cut-off established by the Italian law on WDT [10, 11] for the screening and confirmation analyses on urine are showed in Table 1. A negative urine sample, spiked with all target analytes at the LOD concentrations indicated in Table 1 was analyzed in duplicates in each analytical session.
The GC-MS methods, validated in our laboratory according to the International Conference on Harmonization [19] , are monitored through the participation to the external quality control program of the Society of Toxicological and Forensic Chemistry, Germany (GTFCh). This study was approved by the Ethics Committee of the Second University of Naples (Italy).
RESULTS
The results of the WDT performed from 2001 to 2014 are synthesized in Tables 2-4 and Figure 1 . These show relevant differences in terms of both incidence and in the type of drugs used. The prevalence of the positivity [ Tables 2 and 3 Table 4 .
Cannabis and cocaine are the substances most frequently used, alone or together with other illicit drugs. Interestingly as show in Figure 1 , from 2009 to 2014, the cocaine use among workers has increased from 8% to 19.3%. It happened despite the collapse of positive cases obtained in toxicological controls applied to a nearly constant number of workers. Conversely the use of opiates, methadone and amphetamines alone represents <5% of workers with non-significant differences before and after the application of the mandatory law on WDT.
In the period 2001-2008, the polydrug use involved the 32% of positive cases. Contrariwise, since 2009, it involved only the 8% of positive workers. Table 4 demonstrates that in poly abuse workers cocaine and Cannabis together were the prevalently used substances, before and after 2008. Moreover, both cocaine and Cannabis were frequently present in association with one or more other drugs. 
DISCUSSION
The observed decrease of our epidemiological data about the use of illicit drugs among workers stimulates interesting questions and remarks. Recent studies concerning the application of WDT in different geographical areas of Italy (North -North-East and Central) reported prevalence in drug use among workers comparable with those observed by us since 2009 [20] [21] [22] . They suppose that data about prevalence of the drug use can be influenced by a non-rigorous application of the law mostly during the procedures of the first level (notice periods, sampling, choice of screening tests, etc.). Unfortunately, these studies do not provide data on trends of drug use among workers and on the typology of the substances prevalently used before 2009.
In this study, we observed that the quality assurance in sample collection and in screening/confirmation testing involves many ethical issues and professional responsibilities. The reason is that several critical factors can affect the results and lead to administrative law disputes about use/non-use of illegal drugs. These factors are numerous and not only referred to the specimen collection procedures, the management of chain of custody, and the criteria adopted to verify contamination or adulteration of samples (creatinine, temperature, pH, oxidants, diluents).
In fact, they also refer to the number of tested drugs and relative detection ranges, the cut-off and the reliability of screening tests with regard to the differences in target analytes. Therefore, the professional responsibility for the choice of the screening tests that can be applied in the WDT involves two important factors. The first one is the adherence to the cut-off specified in national legislation. The second one consists in the evaluation of the sensitivity of the screening test compared to the detection time of drugs in urine considering both the occasional and chronic use. After the application of the new law, requiring that the immunoassay tests has to be performed by the specialist in occupational medicine, we observed an increment of the positive cases at screening not confirmed by GC/MS. These false positive results were mainly related to Cannabis (58%), amphetamine or 3,4-methylene-dioxymethamphetamine (26%), opiates (12%) and cocaine (4%). On the contrary, no false positive result was obtained for methadone or buprenorphine. Although false positive results can occur in cases of therapeutic use of pharmaceuticals that interfere with the screening tests (as ephedrine, codeine, oxycodone, lidocaine, ibuprofen, anesthetics used in dentistry, diuretics, antihypertensives, L-dopa, etc.) [23] , this confirm that immunoassay tests may be susceptible to interference not always predictable, especially when managed by personnel not sufficiently trained in the toxicological analysis. Other critical arguments about screening tests involving professional responsibility are related to the fact that the legislation provides (at the first level) a testing for illicit drugs limited to few substances (opiates, cocaine, cannabinoids, methadone, amphetamines, and analogues, buprenorphine).
It also provides that the occupational physician may request toxicological analysis for "other psychotropic substances" which can affect job performance (such as benzodiazepines, barbiturates, and antipsychotics) only "if necessary" and assuming responsibility for it. However, when there is only a suspicion of misuse in the absence of clear clinical symptoms, the occupational physician often finds difficulties to justify the request of toxicological controls "for further other substances." In addition, it should be noted that false negative results can occur if workers have used psychoactive substances (as ketamine, levorphanol, tramadol, hallucinogens, synthetic THC analogues, etc.) not detectable by the screening tests and characterized by barely recognizable clinical symptoms, particularly if there was an occasional use.
For that reason, many dilemmas arise regarding the classification of the negative urines at the first level of examination. For this reason, the law should take into account the possibility to randomly recommend further toxicological analysis (by GC/MS or LC-MS/MS) on negative samples too.
In toxicological controls performed since 2001-2014, either without a specific law or according to mandatory procedures after 2008, we experienced that when the rigorous operative protocols are not followed the WDT can generate many ethical issues and controversial effects. Therefore, because a mandatory WDT could represent a privacy violation and might cause social and occupational marginalization of drug users, it is fundamental the respect for some ethical principles. These principles need to be employed by occupational physician and toxicologists in order to avoid the violation of the worker's rights and prevent disputes or professional responsibility.
These ethical principles include:
• Right to correct and complete information: The employee has to know, ideally prior to taking the job, that abstinence is an expectation, and that WDT is planned • Right to privacy and to physical inviolability: This includes, after the collection of the written informed consent about the WDT, the respect of the privacy about all sensitive health data avoiding the impairment of the right of the physical integrity guaranteed by the Italian Constitutional Law. Therefore, it is the responsibility of the occupational physician the confidential collection of personal data of the employee. This can involve any details about the lifestyle or any therapeutic treatments taking place, also for diseases that do not affect job performance, without divulging these to the employer • Quality assurance in biological sample collection and testing (at screening and confirmation level) in order to prevent damages to workers through false positive results • Support in the counseling in case of a probable addiction and in the transitioning to a more suitable employment, if necessary.
In fact, the urinalysis for drugs, unlike the blood alcohol analysis, is not indicative of the performance of the workers at the job. This is because it does not identify a condition of impairment, but only demonstrates a prior use.
In addition, taking urine samples can be very invasive for the privacy of the employee. In particular, it can result humiliating if the worker must produce a urine sample under the watchful eye of a controller to prevent cheating. Furthermore, the confirmatory analysis requires the management of sophisticated analytical procedures (GC/MS or LC/MS/MS). In fact, if it is not well applied, it can produce misidentification with dramatic consequences for the workers.
CONCLUSION
To explain the decrease of our epidemiological data, two factors were considered as the prevailing ones. The first factor was the deterrent effect that is linked to the mandatory nature of the drug tests. The second one was the behavior often adopted by the occupational physicians that could be classified as "defensive medicine" in order to avoid professional liability or disputes by workers representatives. In fact, the WDT provides that the occupational physician needs to verify a possible use of psychotropic substances that represents a "risk factor" not comparable to the hazards arising from the "occupational exposure" in the workplace.
In this way, the role of the physician as "in charge of health protection" is extended to "controller of the private behavior" of the worker, often causing embarrassment for both parties and disputes. Finally, it is possible that the decrease in the positivity for drug use in the period 2009-2014 could be a consequence of the fact that some occupational physicians are not experienced enough in the evaluation of the toxicological analysis carried out by immunoassay.
Consequently even when the drug testing has a specific role it should be approached with caution and implemented in an ethical, fair, transparent, and inclusive way. Therefore, the consultative role of forensic toxicology laboratories should be extended in order to obtain more accurate epidemiological data (both at first and at second levels) on the drug use among workers. In addition, this could also be done to evaluate the effectiveness of the current legislation in the protection of health and of the safety in the workplace. Moreover, in order to prevent damage to workers, it is an ethical responsibility for the occupational doctors and for the toxicologists that the WDT must be managed with full respect of all analytical, legal, and ethical issues.
